» Articles » PMID: 19581573

Optogenetic Control of Epileptiform Activity

Overview
Specialty Science
Date 2009 Jul 8
PMID 19581573
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

The optogenetic approach to gain control over neuronal excitability both in vitro and in vivo has emerged as a fascinating scientific tool to explore neuronal networks, but it also opens possibilities for developing novel treatment strategies for neurologic conditions. We have explored whether such an optogenetic approach using the light-driven halorhodopsin chloride pump from Natronomonas pharaonis (NpHR), modified for mammalian CNS expression to hyperpolarize central neurons, may inhibit excessive hyperexcitability and epileptiform activity. We show that a lentiviral vector containing the NpHR gene under the calcium/calmodulin-dependent protein kinase IIalpha promoter transduces principal cells of the hippocampus and cortex and hyperpolarizes these cells, preventing generation of action potentials and epileptiform activity during optical stimulation. This study proves a principle, that selective hyperpolarization of principal cortical neurons by NpHR is sufficient to curtail paroxysmal activity in transduced neurons and can inhibit stimulation train-induced bursting in hippocampal organotypic slice cultures, which represents a model tissue of pharmacoresistant epilepsy. This study demonstrates that the optogenetic approach may prove useful for controlling epileptiform activity and opens a future perspective to develop it into a strategy to treat epilepsy.

Citing Articles

State-of-the-art gene therapy in epilepsy.

Walker M Curr Opin Neurol. 2025; 38(2):128-134.

PMID: 39917784 PMC: 11888830. DOI: 10.1097/WCO.0000000000001349.


Suppression of epileptic seizures by transcranial activation of K-selective channelrhodopsin.

Duan X, Zhang C, Wu Y, Ju J, Xu Z, Li X Nat Commun. 2025; 16(1):559.

PMID: 39789018 PMC: 11718177. DOI: 10.1038/s41467-025-55818-w.


Multimodal evaluation of network activity and optogenetic interventions in human hippocampal slices.

Andrews J, Geng J, Voitiuk K, Elliott M, Shin D, Robbins A Nat Neurosci. 2024; 27(12):2487-2499.

PMID: 39548326 PMC: 11881784. DOI: 10.1038/s41593-024-01782-5.


A pH-sensitive closed-loop nanomachine to control hyperexcitability at the single neuron level.

Merolla A, Michetti C, Moschetta M, Vacca F, Ciano L, Emionite L Nat Commun. 2024; 15(1):5609.

PMID: 38965228 PMC: 11224301. DOI: 10.1038/s41467-024-49941-3.


Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer's Disease.

Leitch B Int J Mol Sci. 2024; 25(10).

PMID: 38791587 PMC: 11122153. DOI: 10.3390/ijms25105549.


References
1.
Aziz J, Karakiewicz R, Genov R, Bardakjian B, Derchansky M, Carlen P . Towards real-time in-implant epileptic seizure prediction. Conf Proc IEEE Eng Med Biol Soc. 2007; 2006:5476-9. DOI: 10.1109/IEMBS.2006.259737. View

2.
Staley K . Does plasticity of the GABA(A) reversal potential contribute to epileptogenesis?. Epilepsy Curr. 2008; 8(4):107-10. PMC: 2442156. DOI: 10.1111/j.1535-7511.2008.00259.x. View

3.
Zhang F, Wang L, Boyden E, Deisseroth K . Channelrhodopsin-2 and optical control of excitable cells. Nat Methods. 2006; 3(10):785-92. DOI: 10.1038/nmeth936. View

4.
Kolbe M, Besir H, Essen L, Oesterhelt D . Structure of the light-driven chloride pump halorhodopsin at 1.8 A resolution. Science. 2000; 288(5470):1390-6. DOI: 10.1126/science.288.5470.1390. View

5.
Rivera C, Voipio J, Kaila K . Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII. J Physiol. 2004; 562(Pt 1):27-36. PMC: 1665491. DOI: 10.1113/jphysiol.2004.077495. View